Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report.
Administration, Intravenous
Adult
Antifungal Agents
/ pharmacology
Aspergillus fumigatus
/ drug effects
Bronchoalveolar Lavage Fluid
/ microbiology
Drug Therapy, Combination
/ methods
Female
Humans
Immunocompromised Host
/ immunology
Invasive Pulmonary Aspergillosis
/ drug therapy
Microbial Sensitivity Tests
Myelodysplastic Syndromes
/ immunology
Peripheral Blood Stem Cell Transplantation
/ adverse effects
Aspergillus felis
Cryptic species
Invasive aspergillosis
Myelodysplastic syndrome
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
01
08
2018
revised:
10
10
2018
accepted:
31
10
2018
pubmed:
7
12
2018
medline:
18
6
2019
entrez:
4
12
2018
Statut:
ppublish
Résumé
Aspergillus species are a major cause of life-threatening infections in immunocompromised hosts, and the most common pathogen of invasive aspergillosis is Aspergillus fumigatus. Recently, the development of molecular identification has revealed cryptic Aspergillus species, and A. felis is one such species within the Aspergillus section Fumigati reported in 2013. We describe a case of invasive pulmonary aspergillosis caused by A. felis in a 41-year-old Japanese woman diagnosed with myelodysplastic syndrome. She presented with fever 19 days after undergoing autologous peripheral blood stem cell transplantation and was clinically diagnosed with invasive pulmonary aspergillosis. Bronchoscopy and bronchoalveolar lavage were performed for definitive diagnosis. The β-tubulin genes of the mold isolated from the bronchoalveolar lavage fluid, and sequenced directly from the PCR products using a primer pair were found to have 100% homology with A. felis. We successfully treated the patient with echinocandin following careful susceptibility testing. To the best of our knowledge, this is the first published case reporting the clinical course for diagnosis and successful treatment of invasive aspergillosis by A. felis.
Identifiants
pubmed: 30503017
pii: S1341-321X(18)30449-5
doi: 10.1016/j.jiac.2018.10.016
pii:
doi:
Substances chimiques
Antifungal Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
307-310Informations de copyright
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.